FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

A Shennan, N Suff, B Jacobsson… - … of Gynecology & …, 2021 - Wiley Online Library
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …

Abstracts of the XXIII FIGO World Congress of Gynecology & Obstetrics

A Shennan, N Suff, B Jacobsson… - … and obstetrics: the …, 2021 - pubmed.ncbi.nlm.nih.gov
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …

[HTML][HTML] FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

A Shennan, N Suff, B Jacobsson… - … of Gynaecology and …, 2021 - ncbi.nlm.nih.gov
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …

FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

A Shennan, N Suff, B Jacobsson - International Journal of …, 2021 - research.monash.edu
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …

[PDF][PDF] FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

A Shennan, N Suff, B Jacobsson - 2021 - scholar.archive.org
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …

[PDF][PDF] FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection

A Shennan, N Suff, B Jacobsson - 2021 - fhi.brage.unit.no
In women at risk of early preterm imminent birth, from viability to 30 weeks of gestation, use
of MgSO4 for neuroprotection of the fetus is recommended. In pregnancies below 32–34 …